Early major complications after bariatric surgery in the USA, 2003-2014: a systematic review and meta-analysis.
Su-Hsin ChangN L B FreemanJ A LeeC R T StollA J CalhounJ C EagonG A ColditzPublished in: Obesity reviews : an official journal of the International Association for the Study of Obesity (2017)
The effectiveness of bariatric surgery has been well-studied. However, complications after bariatric surgery have been understudied. This review assesses <30-d major complications associated with bariatric procedures, including anastomotic leak, myocardial infarction and pulmonary embolism. This review included 71 studies conducted in the USA between 2003 and 2014 and 107,874 patients undergoing either gastric bypass, adjustable gastric banding or sleeve gastrectomy, with mean age of 44 years and pre-surgery body mass index of 46.5 kg m-2 . Less than 30-d anastomotic leak rate was 1.15%; myocardial infarction rate was 0.37%; pulmonary embolism rate was 1.17%. Among all patients, mortality rate following anastomotic leak, myocardial infarction and pulmonary embolism was 0.12%, 0.37% and 0.18%, respectively. Among surgical procedures, <30-d after surgery, sleeve gastrectomy (1.21% [95% confidence interval, 0.23-2.19%]) had higher anastomotic leak rate than gastric bypass (1.14% [95% confidence interval, 0.84-1.43%]); gastric bypass had higher rates of myocardial infarction and pulmonary embolism than adjustable gastric banding or sleeve gastrectomy. During the review, we found that the quality of complication reporting is lower than the reporting of other outcomes. In summary, <30-d rates of the three major complications after either one of the procedures range from 0% to 1.55%. Mortality following these complications ranges from 0% to 0.64%. Future studies reporting complications after bariatric surgery should improve their reporting quality.
Keyphrases
- pulmonary embolism
- gastric bypass
- weight loss
- obese patients
- roux en y gastric bypass
- bariatric surgery
- risk factors
- inferior vena cava
- rectal cancer
- heart failure
- left ventricular
- body mass index
- adverse drug
- patients undergoing
- end stage renal disease
- randomized controlled trial
- minimally invasive
- cardiovascular events
- cardiovascular disease
- type diabetes
- weight gain
- coronary artery disease
- quality improvement
- peritoneal dialysis
- atrial fibrillation
- insulin resistance
- adipose tissue
- acute coronary syndrome
- patient reported outcomes
- coronary artery bypass